HLN Stock: Haleon plc Stock Price, Analysis & Insights
Get live HLN stock price $9.15, comprehensive Haleon plc stock analysis, charts, news, and expert forecast. Real-time HLN stock data and investment insights.
Loading chart data...
Haleon plc (HLN) Overview
Haleon plc (HLN) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, HLN trades at $9.15 with a market capitalization of 40.47B . Over the past 52 weeks, HLN has traded between $8.65 and $11.28 , with the current price positioned at approximately 19% of this range . The stock curren...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 40.47B
- Current price: $9.15
- 52-week range: $8.65 - $11.28
- P/E ratio: 18.67
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends a...
Company Information
- CEO
- Brian James McNamara
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 24561
Contact Information
- Website
- https://www.haleon.com
- Address
- Building 5
- Country
- GB
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 18.7)
✓ Lower volatility stock (Beta: 0.25) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Haleon plc shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Haleon plc
- ⚠Investors should consider how Haleon plc fits within their overall portfolio allocation
Market Cap
40.47B
P/E Ratio (TTM)
18.67
Beta
0.25
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare HLN with peer companies:
- Price
- $133.01
- Market cap
- 37.56B
- Price
- $66.94
- Market cap
- 32.63B
- Price
- $150.29
- Market cap
- 54.45B
- Price
- $217.05
- Market cap
- 50.83B
- Price
- $366.89
- Market cap
- 44.05B
- Price
- $94.18
- Market cap
- 20.41B
- Price
- $185.29
- Market cap
- 30.92B
- Price
- $196.10
- Market cap
- 28.44B
- Price
- $15.80
- Market cap
- 49.91B
- Price
- $82.28
- Market cap
- 34.49B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.